Skip to main content
European Journal of Medical Research logoLink to European Journal of Medical Research
. 2020 Oct 30;25:53. doi: 10.1186/s40001-020-00449-8

Correction to: The role of passive immunization in the age of SARS-CoV-2: an update

Johannes C Fischer 1, Kurt Zänker 2, Martijn van Griensven 3, Marion Schneider 4, Detlef Kindgen-Milles 5, Wolfram Trudo Knoefel 6, Artur Lichtenberg 7, Balint Tamaskovics 8, Freddy Joel Djiepmo-Njanang 8, Wilfried Budach 8, Stefanie Corradini 9, Ute Ganswindt 10, Dieter Häussinger 11, Torsten Feldt 11, Hubert Schelzig 12, Hans Bojar 13, Matthias Peiper 14, Edwin Bölke 8,, Jan Haussmann 8, Christiane Matuschek 8
PMCID: PMC7596629  PMID: 33126916

Correction to: Eur J Med Res (2020) 25:16 10.1186/s40001-020-00414-5

Following publication of the original article [1], the authors identified an error in Fig. 1. The corrected Fig. 1 is given below.

Fig. 1.

Fig. 1

High activity natural killer cell during target attack. Footprint of previously attached natural killer cell can be identified by patchy membrane residuals on the target cell surface. Green objects have the size of budding virus particles. When will NK-cells join the cellular immune cascade to fight SARS-CoV-2?

Footnotes

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

References

  • 1.Fischer JC, Zänker K, van Griensven M, Schneider M, Kindgen-Milles D, Knoefel WT, Lichtenberg A, Tamaskovics B, Djiepmo-Njanang FJ, Budach W, Corradini S, Ganswindt U, Häussinger D, Feldt T, Schelzig H, Bojar H, Peiper M, Bölke E, Haussmann J, Matuschek C. The role of passive immunization in the age of SARS-CoV-2: an update. Eur J Med Res. 2020;25:16. doi: 10.1186/s40001-020-00414-5. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from European Journal of Medical Research are provided here courtesy of BMC

RESOURCES